^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Childhood B Acute Lymphoblastic Leukemia |
| Drug: | bortezomib (Proteasome inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Pediatric Acute Lymphoblastic Leukemia: Other Recommended Regimens…Bortezomib-containing regimen: eg, bortezomib, vincristine, doxorubicin, pegaspargase, and prednisone or dexamethasone.
Secondary therapy:
doxorubicin hydrochloride + vincristine + prednisone + pegaspargase; doxorubicin hydrochloride + vincristine + dexamethasone + pegaspargase
